Once the bioluminescent tumour signal became apparent, the animals were randomised to receive anti-mouse VEGFR2 blocking antibody (DC101), EGFR inhibitor (DAC), both, or vehicle controls (IgG, Lactate; Fig. 5a; Supplementary Fig. 16a, b;). This evidence concerns the gene KDR and neoplasm.